Zhejiang Medicine Co Ltd (600216) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.062x

Based on the latest financial reports, Zhejiang Medicine Co Ltd (600216) has a cash flow conversion efficiency ratio of 0.062x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥690.77 Million ≈ $101.08 Million USD) by net assets (CN¥11.21 Billion ≈ $1.64 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 600216 market cap for the company's overall valuation and market capitalisation.

Zhejiang Medicine Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)

This chart illustrates how Zhejiang Medicine Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Zhejiang Medicine Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Medicine Co Ltd ranked by their cash flow conversion efficiency. Explore Zhejiang Medicine Co Ltd (600216) cash earnings ratio to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Dime Community Bancshares, Inc.
NYSE:DCOM
0.037x
OVH Groupe SAS
PA:OVH
10.219x
Zydus Wellness Limited
NSE:ZYDUSWELL
0.070x
Tianjin Port Co Ltd
SHG:600717
0.036x
Zymeworks Inc. Common Stock
NASDAQ:ZYME
-0.098x
Woolworths Holdings Ltd
JSE:WHL
0.247x
Guangdong Rongtai Industry Co Ltd
SHG:600589
-0.022x
National Bank Holdings Corporation
NYSE:NBHC
0.081x

Annual Cash Flow Conversion Efficiency for Zhejiang Medicine Co Ltd (1998–2025)

The table below shows the annual cash flow conversion efficiency of Zhejiang Medicine Co Ltd from 1998 to 2025. View Zhejiang Medicine Co Ltd (600216) stock price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥11.09 Billion
≈ $1.62 Billion
CN¥1.89 Billion
≈ $275.95 Million
0.170x +51.08%
2024-12-31 CN¥10.87 Billion
≈ $1.59 Billion
CN¥1.22 Billion
≈ $179.01 Million
0.113x +77.21%
2023-12-31 CN¥9.99 Billion
≈ $1.46 Billion
CN¥634.31 Million
≈ $92.82 Million
0.064x +18.47%
2022-12-31 CN¥9.71 Billion
≈ $1.42 Billion
CN¥520.60 Million
≈ $76.18 Million
0.054x -56.69%
2021-12-31 CN¥9.18 Billion
≈ $1.34 Billion
CN¥1.14 Billion
≈ $166.33 Million
0.124x -20.90%
2020-12-31 CN¥8.03 Billion
≈ $1.18 Billion
CN¥1.26 Billion
≈ $183.90 Million
0.157x +188.76%
2019-12-31 CN¥8.25 Billion
≈ $1.21 Billion
CN¥447.25 Million
≈ $65.45 Million
0.054x -24.45%
2018-12-31 CN¥8.08 Billion
≈ $1.18 Billion
CN¥579.91 Million
≈ $84.86 Million
0.072x +10.84%
2017-12-31 CN¥7.78 Billion
≈ $1.14 Billion
CN¥503.47 Million
≈ $73.67 Million
0.065x +34.62%
2016-12-31 CN¥6.99 Billion
≈ $1.02 Billion
CN¥336.14 Million
≈ $49.19 Million
0.048x +198.51%
2015-12-31 CN¥6.62 Billion
≈ $968.00 Million
CN¥106.54 Million
≈ $15.59 Million
0.016x -80.78%
2014-12-31 CN¥6.56 Billion
≈ $960.18 Million
CN¥549.90 Million
≈ $80.47 Million
0.084x -17.10%
2013-12-31 CN¥6.48 Billion
≈ $948.29 Million
CN¥655.09 Million
≈ $95.86 Million
0.101x -22.42%
2012-12-31 CN¥6.20 Billion
≈ $906.81 Million
CN¥807.49 Million
≈ $118.16 Million
0.130x -37.18%
2011-12-31 CN¥4.40 Billion
≈ $643.92 Million
CN¥912.75 Million
≈ $133.56 Million
0.207x -39.12%
2010-12-31 CN¥3.86 Billion
≈ $565.33 Million
CN¥1.32 Billion
≈ $192.62 Million
0.341x -33.46%
2009-12-31 CN¥2.86 Billion
≈ $418.70 Million
CN¥1.47 Billion
≈ $214.39 Million
0.512x -22.67%
2008-12-31 CN¥1.81 Billion
≈ $265.19 Million
CN¥1.20 Billion
≈ $175.59 Million
0.662x +154.11%
2007-12-31 CN¥873.73 Million
≈ $127.85 Million
CN¥227.67 Million
≈ $33.32 Million
0.261x +19.49%
2006-12-31 CN¥777.31 Million
≈ $113.74 Million
CN¥169.51 Million
≈ $24.80 Million
0.218x +535.06%
2005-12-31 CN¥732.23 Million
≈ $107.15 Million
CN¥25.14 Million
≈ $3.68 Million
0.034x -79.39%
2004-12-31 CN¥645.68 Million
≈ $94.48 Million
CN¥107.60 Million
≈ $15.75 Million
0.167x +58.20%
2003-12-31 CN¥628.48 Million
≈ $91.97 Million
CN¥66.20 Million
≈ $9.69 Million
0.105x +186.82%
2002-12-31 CN¥629.71 Million
≈ $92.15 Million
CN¥23.13 Million
≈ $3.38 Million
0.037x -77.25%
2001-12-31 CN¥608.50 Million
≈ $89.04 Million
CN¥98.25 Million
≈ $14.38 Million
0.161x +868.83%
2000-12-31 CN¥635.03 Million
≈ $92.92 Million
CN¥10.58 Million
≈ $1.55 Million
0.017x +120.07%
1999-12-31 CN¥625.07 Million
≈ $91.47 Million
CN¥-51.90 Million
≈ $-7.60 Million
-0.083x -150.15%
1998-12-31 CN¥348.61 Million
≈ $51.01 Million
CN¥57.72 Million
≈ $8.45 Million
0.166x --

About Zhejiang Medicine Co Ltd

SHG:600216 China Drug Manufacturers - Specialty & Generic
Market Cap
$1.79 Billion
CN¥12.23 Billion CNY
Market Cap Rank
#6632 Global
#1356 in China
Share Price
CN¥12.72
Change (1 day)
-0.78%
52-Week Range
CN¥11.29 - CN¥18.38
All Time High
CN¥20.16
About

Zhejiang Medicine Co., Ltd. manufactures and sells life nutrition and pharmaceuticals products in China and internationally. The company offers synthetic vitamin E, vitamin A, natural vitamin E, ß-carotene, canthaxanthin, vancomycin hydrochloride, teicoplanin, and daptomycin. It also provides fat-soluble vitamins, quinolone antibiotics, anti-drug-resistant antibiotics, and other products, as well… Read more